entity

glycine-rich_domain

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about glycine-rich_domain: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
1Hypotheses
1Analyses
2Outgoing
0Incoming
10Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
TDP-43_phase_separationactivatesmechanism0.80
hnRNP_interactionregulatesmechanism0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Glycine-Rich Domain Competitive Inhibition 0.640 neurodegeneration TDP-43 phase separation therapeutics for

Mentioning Analyses (1)

Scientific analyses that reference this entity

TDP-43 phase separation therapeutics for ALS-FTD

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TDP-43 mutant mouse model cGAS/STING pathway analysis validation amyotrophic lateral sclerosis 0.900 0.00 TDP-43 mutant mice proposed N/A
TDP-43 mitochondrial invasion and DNA release via mPTP exploratory amyotrophic lateral sclerosis 0.900 0.00 cultured cells proposed N/A
TDP-43 mitochondrial invasion and mtDNA release in iPSC motor neurons exploratory Amyotrophic Lateral Sclerosis 0.900 0.00 iPSC-derived motor neurons proposed N/A
cGAS/STING pathway validation in TDP-43 mutant mice validation Amyotrophic Lateral Sclerosis 0.850 0.00 TDP-43 mutant mice proposed N/A
cGAMP biomarker analysis in ALS patient spinal cord samples exploratory Amyotrophic Lateral Sclerosis 0.800 0.00 Human ALS patient spinal cord proposed N/A
TDP-43 pathology prevalence and distribution in AD cases exploratory Alzheimer's disease 0.800 0.00 human postmortem brain tissue proposed N/A
Cognitive impact of TDP-43 pathology in AD patients clinical Alzheimer's disease 0.700 0.00 human patients completed N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
s:** - Single-cell RNA-seq to measure editing efficiency across differ falsification ALS 0.400 0.50 cell_line proposed $150,000
ALS Progression Rate Heterogeneity — mechanism and biomarker predictor clinical ALS 0.400 0.50 human proposed $6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] Chua JP, De Calbiac H, Kabashi E, Barmad Autophagy 2022 2
TDP-43 Pathology in Alzheimer's Disease. [PMID:34930382] Meneses A, Koga S, O'Leary J, Dickson DW Mol Neurodegener 2021 2
Protein transmission in neurodegenerative disease. [PMID:32203399] Peng C, Trojanowski JQ, Lee VM Nat Rev Neurol 2020 2
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591] Rusmini P, Cortese K, Crippa V, Cristofa Autophagy 2019 2
N protein of PEDV plays chess game with host proteins by selective autophagy. [PMID:36861818] Zhai X, Kong N, Zhang Y, Song Y, Qin W, Autophagy 2023 1
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. [PMID:36754049] Hung ST, Linares GR, Chang WH, Eoh Y, Kr Cell 2023 1
Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral [PMID:41897327] Romano R, Ruotolo G, Perrone F, Tomasell Biomolecules 2026 0
Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Protein [PMID:41900026] Jamerlan A, Hulme J Molecules (Basel, Switzerland) 2026 0
Axonal transport impairment as an upstream mechanism in amyotrophic lateral scle [PMID:41890591] Gabbay U Frontiers in neuroscience 2026 0
Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA- [PMID:41512823] ["Guo L", "Mann J", "Mauna J", "Copley K Molecular cell 2026 0
The Genetics of TDP-43 Type C Neurodegeneration: A Whole-Genome Sequencing Study [PMID:41883703] Nassan M, Ayala I, Sloan J, Bonfitto A, Neurology. Genetics 2026 0
Excitotoxicity in amyotrophic lateral sclerosis: a key pathogenic mechanism. [PMID:41890274] Silva-Hucha S, Hernández RG, Baena-López Brain communications 2026 0
Direct observation and quantification of single nanocondensates of the low compl [PMID:41654570] ["Houx J", "Cussac J", "Copie T", "Gambi Nature communications 2026 0
Small heat shock protein HSPB8 interacts with a pre-fibrillar TDP43 low complexi [PMID:41690263] ["Jami K", "Corbett K", "Farb D", "Osumi Biophysical chemistry 2026 0
Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibr [PMID:41609580] ["Purvinsh Y", "Matveyenka M", "Kurouski ACS chemical neuroscience 2026 0
Inertial Agitation in an NMR Magnet: Real-Time Monitoring of Protein Aggregation [PMID:41397930] ["Lee J", "Jung S", "Yu S", "Park S", "K Journal of the American Chemic 2025 0
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD. [PMID:38277467] Seddighi S, Qi YA, Brown AL, Wilkins OG, Science translational medicine 2024 0
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 0
C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. [PMID:32878979] Cook CN, Wu Y, Odeh HM, Gendron TF, Jans Science translational medicine 2020 0

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying tdp-43 phase separation therapeutics for als-

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning glycine-rich_domain in their description or question text

No additional research found